Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-Administered Vaginal Misoprostol for Cervical Ripening
NCT00363389Phase 3Completed
- Sponsor
- Ullevål University Hospital
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in Abnormal uterine bleeding (AUB), sponsored by Ullevål University Hospital. Primary endpoint: Mean pre-operative baseline cervical dilatation at 24 hours. Started Sep 2006; status: completed.
02
Drugs
misoprostol
03
Conditions
Abnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT00363389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363389.